Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gilbert

Showing results (1351-1360 of 1,457) with videos related to

Pageof 146
Sort By:
Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology Advances|February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findingsNicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Iscience|April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology|May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patientsAmy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Molecular Autism|April 5, 2012
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate lociDale J Hedges, Kara L Hamilton-Nelson, Stephanie J Sacharow, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancerVivian Wai Yan Lui, Noah D Peyser, Patrick Kwok-Shing Ng, et al.
Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.
Neuro-Oncology|November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.
Pageof 146

Showing results (1351-1360 of 1,457) with videos related to

Sort By:
Pageof 146
Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.
Neuro-Oncology Advances|February 29, 2024
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findingsNicole Briceno, Elizabeth Vera, Edina Komlodi-Pasztor, et al.
Iscience|April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology|May 15, 2016
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patientsAmy K LeBlanc, Christina Mazcko, Diane E Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Molecular Autism|April 5, 2012
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate lociDale J Hedges, Kara L Hamilton-Nelson, Stephanie J Sacharow, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancerVivian Wai Yan Lui, Noah D Peyser, Patrick Kwok-Shing Ng, et al.
Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.
Neuro-Oncology|November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.
Pageof 146